The Role of Fas in Apoptosis Induced by Anticancer Drugs
Open Access
- 1 January 1999
- journal article
- editorial
- Published by Wolters Kluwer Health in Hepatology
- Vol. 29 (1) , 280-281
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Apoptosis in Human Hepatoma Cell Lines by Chemotherapeutic Drugs Via Fas–Dependent and Fas–Independent PathwaysHepatology, 1999
- A model for p53-induced apoptosisNature, 1997
- FLICE is activated by association with the CD95 death‐inducing signaling complex (DISC)The EMBO Journal, 1997
- The Receptor for the Cytotoxic Ligand TRAILScience, 1997
- Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53.Journal of Clinical Investigation, 1997
- Apoptosis by Death FactorCell, 1997
- RAIDD is a new 'death' adaptor moleculeNature, 1997
- Signal Transduction by DR3, a Death Domain-Containing Receptor Related to TNFR-1 and CD95Science, 1996
- Identification and characterization of a new member of the TNF family that induces apoptosisImmunity, 1995
- Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: correlation with tumour stage and patient survivalBritish Journal of Cancer, 1995